Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Uncertain Efficacy: Oral tirzepatide's effectiveness is unproven and highly variable, due to lack of regulation and standardized production
doi: 10.3109/07420528.2014.897711 29 MochelJPDanhofM
SNAC was associated with increased gestation length, stillbirths, and decreased pup viability following oral dosing in pregnant rats during gestation and lactation
Current evidence from animal models shows potential concerns with reproductive outcomes, which is why regulatory guidance suggests avoiding tirzepatide throughout pregnancy and breastfeeding periods
Endpoints & analytics
Its triple agonism allows simultaneous study of combined GLP-1 + GIP + glucagon effects, experimental dissections impossible with mono-agonists or dual agonists
US$ 26.84
US$ 22.48
US$ 27.09
US$ 24.64
US$ 25.47
